Literature DB >> 21343595

Diabetes and antiplatelet therapy in acute coronary syndrome.

José Luis Ferreiro1, Dominick J Angiolillo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21343595     DOI： 10.1161/CIRCULATIONAHA.109.913376

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  73 in total

1.  Glucose and collagen regulate human platelet activity through aldose reductase induction of thromboxane.

Authors:  Wai Ho Tang; Jeremiah Stitham; Scott Gleim; Concetta Di Febbo; Ettore Porreca; Cristiano Fava; Stefania Tacconelli; Marta Capone; Virgilio Evangelista; Giacomo Levantesi; Li Wen; Kathleen Martin; Pietro Minuz; Jeffrey Rade; Paola Patrignani; John Hwa
Journal:  J Clin Invest       Date:  2011-10-17       Impact factor: 14.808

Review 2.  Role of New Antiplatelet Drugs on Cardiovascular Disease: Update on Cangrelor.

Authors:  Ana Lucrecia Marcano; José Luis Ferreiro
Journal:  Curr Atheroscler Rep       Date:  2016-11       Impact factor: 5.113

3.  Low-dose aspirin for primary cardiovascular prevention in diabetic patients: the issue to believe it or not.

Authors:  Priscilla Lamendola; Angelo Villano; Augusto Fusco; Massimo Leggio
Journal:  Ann Transl Med       Date:  2018-06

4.  Impact of impaired glucose tolerance on clopidogrel response in patients with coronary artery disease.

Authors:  Masafumi Ueno; Kosuke Fujita; Hiroyuki Yamamoto; Tomoyuki Ikeda; Tatsuya Suga; Kenji Yamaji; Shinichiro Ikuta; Kazuhiro Kobuke; Yoshitaka Iwanaga; Dominick J Angiolillo; Shunichi Miyazaki
Journal:  J Thromb Thrombolysis       Date:  2015-08       Impact factor: 2.300

5.  Effects of cangrelor in coronary artery disease patients with and without diabetes mellitus: an in vitro pharmacodynamic investigation.

Authors:  José L Ferreiro; Masafumi Ueno; Antonio Tello-Montoliu; Salvatore D Tomasello; Davide Capodanno; Piera Capranzano; Kodlipet Dharmashankar; Andrew Darlington; Bhaloo Desai; Fabiana Rollini; Luis A Guzman; Theodore A Bass; Dominick J Angiolillo
Journal:  J Thromb Thrombolysis       Date:  2013-02       Impact factor: 2.300

6.  Ischemic and bleeding risk by type 2 diabetes clusters in patients with acute coronary syndrome.

Authors:  Ilaria Cavallari; Ernesto Maddaloni; Felice Gragnano; Giuseppe Patti; Emilia Antonucci; Paolo Calabrò; Plinio Cirillo; Paolo Gresele; Gualtiero Palareti; Vittorio Pengo; Pasquale Pignatelli; Rossella Marcucci
Journal:  Intern Emerg Med       Date:  2021-02-22       Impact factor: 3.397

Review 7.  Percutaneous versus surgical interventions for coronary artery disease in those with diabetes mellitus.

Authors:  Ozlem Soran
Journal:  Curr Cardiol Rep       Date:  2013-01       Impact factor: 2.931

Review 8.  THE IMPACT OF CARDIOVASCULAR DRUGS ON GLYCEMIC CONTROL: A REVIEW.

Authors:  Anna Grodzinsky; Suzanne V Arnold; Dany Jacob; Boris Draznin; Mikhail Kosiborod
Journal:  Endocr Pract       Date:  2016-12-14       Impact factor: 3.443

9.  Impact of diabetes on immature platelets fraction and its relationship with platelet reactivity in patients receiving dual antiplatelet therapy.

Authors:  Monica Verdoia; Patrizia Pergolini; Matteo Nardin; Roberta Rolla; Lucia Barbieri; Alon Schaffer; Paolo Marino; Giorgio Bellomo; Harry Suryapranata; Giuseppe De Luca
Journal:  J Thromb Thrombolysis       Date:  2016-08       Impact factor: 2.300

Review 10.  Aspirin for Primary Prevention of Cardiovascular Disease in Diabetes: a Review of the Evidence.

Authors:  Mohammed E Al-Sofiani; Robert Derenbecker; Michael Quartuccio; Rita R Kalyani
Journal:  Curr Diab Rep       Date:  2019-09-23       Impact factor: 4.810
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.